Shea, M., Huberman, M. S., & Costa, D. B. (2016). Lazarus-type response to crizotinib in a patient with poor performance status and advanced MET exon 14 skipping mutation-positive lung adenocarcinoma. J Thorac Oncol.
Styl ChicagoShea, Meghan, Mark S. Huberman, a Daniel B. Costa. "Lazarus-type Response to Crizotinib in a Patient With Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-positive Lung Adenocarcinoma." J Thorac Oncol 2016.
Citace podle MLAShea, Meghan, Mark S. Huberman, a Daniel B. Costa. "Lazarus-type Response to Crizotinib in a Patient With Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-positive Lung Adenocarcinoma." J Thorac Oncol 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..